The DCB is meant to address long-term stent-related complications and avoid adding yet another metal layer in ISR.

The real-world Evoque and new TRILUMINATE findings provide an “extension” from the pivotal trials, Dharam Kumbhani says.

“Cutting balloon angioplasty is a reasonable and less costly option when compared with intravascular lithotripsy for the ...

The first of its kind RCT in acute intermediate-high-risk PE used a surrogate endpoint, but more data are on the horizon.